Track the 바이오스마트 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Technology sector, 바이오스마트 has published 24 insider filings. Market capitalisation: €70.1bn. The latest transaction was reported on 9 April 2026 (Purchase). Among the most active insiders: 박혜린. The full history is openly available.
24
Insider Decl.
0
Thresholds
·
15 ops.
Buy Volume
·
0 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 14,663 of 25,567 companies
47.6
score / 100
Value
65
Quality
31
FCF yld-15%
Earn yld14%
EV/EBITDA5.6x
ROE·
Gross mgn18%
Net mgn1.9%
Debt/EBITDA3.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.